Vaccination of patients with psoriasis is a special category that should always follow the instructions of dermatologists.
You can study the instructions from the EuroGuiDerm on covid-19 vaccination in patients with psoriasis summarised below:
- Vaccination of patients with psoriasis with the approved vaccines for Covid-19 is recommended. The vaccines are safe in psoriatic patients under immunosuppressive treatment.
- During the vaccination period, treatment for psoriasis should not be interrupted. If possible, it is recommended that vaccination be scheduled in the middle of the interval between 2 applications of the medication. For patients receiving cyclosporine, methotrexate, tofacitinib a short interruption of treatment after vaccination is recommended.
- Since the effectiveness of vaccination cannot be guaranteed, patients on systemic treatment should continue to follow prophylactic strategies (e.g. masks and social distancing measures).
- Patients with psoriasis should have other vaccinations, such as for influenza and pneumococcus.
- Early studies suggest that some patients with autoimmune, inflammatory diseases under immunosuppressive treatment may have a reduced response to mRNA vaccines for Covid-19 disease. Therefore, the third dose of the vaccine is recommended at least 28 days after the second dose.
- Booster doses of the vaccine should be in accordance with local policies.
